Whitehawk Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
516
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
WHWK
Whitehawk Therapeutics, Inc. is a preclinical-stage oncology company focused on developing advanced antibody-drug conjugate (ADC) therapies. The company applies next-wave platform technologies to established tumor biology to create treatments for difficult-to-treat cancers. Its portfolio features three ADC assets, which are engineered to overcome the limitations of first-generation predecessors through improved tumor targeting and clinical strategies. These assets are in-licensed from WuXi Biologics under an exclusive agreement for global development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 | 2026-05-29 | English | |
| 8-K | 2026-05-21 | English | |
| 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-13 | English | |
| 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-07 | English | |
| 3 Filing | 2025-12-02 | English | |
| 4 Filing | 2025-12-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 47894348 | S-3 | 2026-05-29 | English | ||
| 46754058 | 8-K | 2026-05-21 | English | ||
| 45579684 | 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-13 | English | ||
| 42980779 | 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-07 | English | ||
|
2025
11 filings
| |||||
| 29677370 | 3 Filing | 2025-12-02 | English | ||
| 29675686 | 4 Filing | 2025-12-02 | English | ||
| 29677454 | 10-Q Filing | 2025-11-06 | English | ||
| 29675803 | 8-K Filing | 2025-11-06 | English | ||
| 29677316 | SCHEDULE 13G Filing | 2025-08-25 | English | ||
| 29677462 | 10-Q Filing | 2025-08-07 | English | ||
| 29677395 | 8-K Filing | 2025-08-07 | English | ||
| 29675718 | 4 Filing | 2025-06-17 | English | ||
| 29675501 | 4 Filing | 2025-06-17 | English | ||
| 29677439 | 4 Filing | 2025-06-16 | English | ||
| 29677425 | 4 Filing | 2025-06-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
NOVOPROTEIN SCIENTIFIC INC.
Develops recombinant proteins and enzymes for life sciences…
|
688137 | CN | Professional, scientific and te… |
|
NOXOPHARM LIMITED
Clinical-stage developer of novel treatments for cancer and…
|
NOX | AU | Professional, scientific and te… |
|
NUFORMIX PLC
Pharmaceutical developer using cocrystal technology to repu…
|
NFX | GB | Professional, scientific and te… |
|
Nurix Therapeutics, Inc.
Clinical-stage biopharma developing protein degradation the…
|
NRIX | US | Professional, scientific and te… |
|
NYRADA INC.
Develops small molecule therapeutics for cardiovascular hea…
|
NYR | AU | Professional, scientific and te… |
|
OLIPASS CORPORATION
An R&D company developing RNA therapeutics using its propri…
|
244460 | KR | Professional, scientific and te… |
|
OmniAb, Inc.
A technology platform for therapeutic antibody discovery us…
|
OABIW | US | Professional, scientific and te… |
|
ONCIMMUNE HOLDINGS PLC
Immunodiagnostics company specializing in antibody and auto…
|
ONC | GB | Professional, scientific and te… |
|
Oncocross Co.,Ltd.
An AI biotechnology firm that develops drugs by predicting …
|
382150 | KR | Professional, scientific and te… |
|
ONCODESIGN
Develops therapeutic and diagnostic solutions for resistant…
|
ALONC | FR | Professional, scientific and te… |
Whitehawk Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34276/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34276 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34276 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34276 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34276}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Whitehawk Therapeutics, Inc. (id: 34276)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.